首页> 外文OA文献 >Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design

【2h】

Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design

机译：临床药代动力学和药物相互作用中的乳腺癌耐药蛋白（aBCG2）：临床受害者和犯罪者药物 - 药物相互作用研究设计的实用建议

页面导航

著录项
相似文献
相关主题

著录项

作者
Lee CA; OConnor MA; Ritchie TK; Galetin A; Cook JA; Ragueneau-Majlessi I; Ellens H; Feng B; Taub ME; Paine MF; Polli JW; Ware JA; Zamek-Gliszczynski MJ;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design [J] . Lee Caroline A., OConnor Meeghan A., Ritchie Tasha K., Drug Metabolism and Disposition: The Biological Fate of Chemicals . 2015,第4期

机译：临床药代动力学和药物相互作用中的乳腺癌抗性蛋白（ABCG2）：临床受害者和作案者药物相互作用研究设计的实用建议
2. Local Drug-Drug Interaction of Donepezil with Cilostazol at Breast Cancer Resistance Protein (ABCG2) Increases Drug Accumulation in Heart [J] . Takeuchi Ryota, Shinozaki Kohki, Nakanishi Takeo, Drug Metabolism and Disposition: The Biological Fate of Chemicals . 2016,第1期

机译：多奈哌齐与西洛他唑在乳腺癌抗性蛋白（ABCG2）上的局部药物相互作用增加了心脏中的药物蓄积
3. Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure [J] . Elsby Robert, Martin Paul, Surry Dominic, Drug Metabolism and Disposition: The Biological Fate of Chemicals . 2016,第3期

机译：乳腺癌抵抗蛋白外排转运蛋白的单独抑制导致瑞舒伐他汀在临床上具有重要的药物相互作用，其引起的他汀类药物暴露量最多增加2倍
4. Implementation of Clinical Decision Support Services to Detect Potential Drug-Drug Interaction Using Clinical Quality Language [C] . Binh-Phi Nguyen, Thomas Reese, Stefen Decker, MEDINFO . 2019

机译：临床决策支持服务的实施，以检测临床素质的潜在药物 - 药物互动
5. Clinical Significance and Regulatory Framework for the Evaluation of Organic Anion Transporting Polypeptide 1B-Based Drug-Drug Interactions [D] . McFeely, Savannah Jane Kerr. 2019

机译：用于评价有机阴离子输送多肽1B基药物相互作用的临床意义和监管框架
6. Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations [O] . Laura M. Spring, Mark L. Zangardi, Beverly Moy, 2017

机译：乳腺癌中与细胞周期蛋白依赖性激酶4/6抑制剂相关的潜在毒性和药物相互作用的临床管理：实际考虑和建议
7. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions [O] . Breedveld, Pauline, Zelcer, Noam, Pluim, Dick, 2004

机译：甲氨蝶呤和苯并咪唑之间药代动力学相互作用的机制：乳腺癌耐药蛋白在临床药物相互作用中的潜在作用

Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design

著录项

相似文献

相关主题

期刊订阅